Pharmaceutically important pre- and posttranslational modifications on human serum albumin.

doi:10.1248/bpb.32.527

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Pharmaceutically important pre- and posttranslational modifications on human serum albumin.

Biological & pharmaceutical bulletin - 1 Apr 2009

Otagiri Masaki, Chuang Victor Tuan Giam

Abstract excerpt

Recombinant technology allows engineering and production of proteins with desirable properties. Human serum albumin has been developed with recombinant technology, and thus plays an increasing role as a drug carrier in the clinical setting. Genetic variations usually occur on the surface of the protein, and do not impose significant effects on the conformation of albumin. However, binding of fatty acids by...

Topics

Genetic Variation
Humans
Models, Molecular
Protein Processing, Post-Translational
Serum Albumin

Source

Open in PubMed

Identifiers

PMID: 19336879
DOI: 10.1248/bpb.32.527

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics